제품 세부정보
FAB
- Simple and fast operation - No complicated washing steps, significantly reducing time.
- High batch consistency - Strict control over raw materials and finished product quality, ensuring a stable supply.
- Accurate and reliable results - High sensitivity with minimal matrix effects.
- High throughput capability - Support multiple product specifications, ideal for high-throughput screening.
- Fast completion - Results in just 1 hour.
Product Specifications
Assay TypeCompetition-TR-FRETReactivityHumanRegulatory StatusRUOAssay Time1 hrSample volume10 μLProduct Overview
The Human IL-4 / IL-4RA Inhibitor Screening Kit (TR-FRET) is based on a homogeneous (no wash) competition TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screening for inhibitors of human IL-4 binding to human IL-4RA within 0.5-1 hours. It can also be used as a universal detection tool to identify the ability of human IL-4 to bind to human IL-4RA.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeFRTP009-C01Human IL-4 Protein Europium-chelate100 tests/500 testsFRTP009-C02FA Labeled Human IL-4RA Protein100 tests/500 testsFRTP009-C03Anti-IL-4RA Neutralizing Antibody30 μg/100 tests 150 μg/500 testsDB-04TR-FRET Sample Dilution Buffer, pH7.450 mL/100 tests & 150 testsDB-05TR-FRET Detection Buffer, pH7.450 mL/100 tests & 500 testsAssay Principles
This Human IL-4 / IL-4RA Inhibitor Screening Kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). This assay uses the mixture of biotinylated human IL-4 and Europium-chelate labeled streptavidin as the Donor and FA Labeled Human IL-4RA Protein as the Acceptor.
— When the sample does not contain the inhibitors that block the binding of human IL-4 to human IL-4RA, the Donor and Acceptor are in close proximity because of the binding of human IL-4 and human IL-4RA. Upon Donor excitation with light of a specific wavelength (337nm), in addition to Donor emission (620nm), non-radiative transfer of energy occurs between Donor and Acceptor, resulting in Acceptor emission (665nm).
— When the sample contains the inhibitors that block the binding of human IL-4 to human IL-4RA, the components inhibit the binding between the Donor and Acceptor and thereby prevent FRET from occurring.

ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
Bioactivity-TR-FRET
Please refer to DS document for the assay protocol.

In this TR-FRET assay, Human IL-4 Protein Europium-chelate is used as the Donor and FA Labeled Human IL-4RA Protein is used as the Acceptor. An inhibition Assay was performed to evaluate the interaction between human IL-4 and human IL-4RA using Anti-IL-4RA Neutralizing Antibody resulting in a typical IC50 of 0.7685 nM (QC tested).
사용자 리뷰 댓글 남기기

프론티어 진행
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

















